I
Immatics NV D
D
IMTX
6.56000
USD
0.09
(1.39%)
مغلق
حجم التداول
0
الربح لكل سهم
0
العائد الربحي
-
P/E
-33
حجم السوق
797,369,109
الأخبار المقالات
العنوان: Immatics NV
القطاع: Healthcare
الصناعة: Biotechnology
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.